CD4 and melanoma: Hence, their study in unsorted scRNA-seq from patients with cancer requires specific isolation of CD4-expressing cytotoxic cells, which was done in reanalysis of published data to provide evidence for cytotoxic CD4+ T cells in breast cancer, head and neck cancer, melanoma, and liver cancer (8).